Nanometric gold in cancer nanotechnology: Current status and future prospect

85Citations
Citations of this article
138Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objectives This review elaborate on modified gold nanoparticulate concept in oncology, provides an overview of the use of gold nanoparticles in cancer treatment and discusses their potential applications and clinical benefits. Key findings Modified gold nanoparticles (e.g. rod, multipod and star or a hollow structure such as shell, box and cage) have promising applications in the fields of drug delivery and photothermal therapy in oncology due to their unique optical and photothermal properties and their ability to modify the surface and conjugate drugs/molecules with gold nanomaterial. Modified gold nanoparticles exhibit strong light absorption in the near-infrared region in which light can penetrate deeply into soft tissue. Moreover, recent advances have opened the way to site-specific delivery by gold nanoparticle. Summary Recent research and development in cancer-targeted gold nanovectors shows promise for maximizing the efficacy of anti-cancer drugs while decreasing their harmful systemic effects in chemotherapy. Moreover, gold nanoparticles can also serve as cancer therapeutic. © 2012 The Authors. JPP © 2012. Royal Pharmaceutical Society.

Cite

CITATION STYLE

APA

Ahmad, M. Z., Akhter, S., Rahman, Z., Akhter, S., Anwar, M., Mallik, N., & Ahmad, F. J. (2013, May). Nanometric gold in cancer nanotechnology: Current status and future prospect. Journal of Pharmacy and Pharmacology. https://doi.org/10.1111/jphp.12017

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free